Role of transcription factors in inflammatory lung diseases

Thorax

Volumn 53, Issue 7, 1998, Pages 601-612

  Rahman, Irfan ^a   MacNee, William ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTIOXIDANT; CELL NUCLEUS RECEPTOR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYTOKINE; DNA; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBITOR PROTEIN; LIPOXYGENASE INHIBITOR; NUCLEAR FACTOR; ONCOPROTEIN; PROSTAGLANDIN SYNTHASE INHIBITOR; PROTEINASE INHIBITOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1; VIRUS PROTEIN;

ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; HUMAN; INFLAMMATORY DISEASE; LUNG DISEASE; ONCOGENE C FOS; ONCOGENE C JUN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE ACTIVATION;

EID: 0031840980     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.53.7.601     Document Type: Review

References (119)

1. Brennan FM, Maini RN, Feldmann M. Cytokine expression in chronic inflammatory disease. Br Med Bull 1995;51:368-84.
2. Rahman I, MacNee W. Oxidant/antioxidant imbalance in smokers and chronic obstructive pulmonary disease. Thorax 1996;51:348-50.
3. Thompson AB, Robbins RA, Romberger DJ, et al. Immunological functions of the pulmonary epithelium. Eur Respir J 1995;8:127-49.
4. Papavassiliou AG. Transcription factors. N Engl J Med 1995;332:45-7.
5. Barnes PJ, Karin M. Nuclear factor-κB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997;336:1066-71.
6. Rao A, Luo C, Hogan PG. Transcription factors of the NFAT family: regulation and function. Annu Rev Immunol 1997;15:707-47.
7. Akira S, Kishimoto T. NF-IL6 and NF-κB in cytokine gene regulation. Adv Immunol 1997;65:1-46.
8. Glass CK, Rose DW, Rosenfeld MG. Nuclear receptor co-activators. Current Opin Cell Biol 1997;9:222-32.
9. Sen R, Baltimore D. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 1986;46: 705-16.
10. Baldwin AS Jr. The NF-κB and IκB proteins: new discoveries and insights. Annu Rev Immunol 1996;14:649-83.
11. DiDonato J, Mercurio F, Rosette O, et al. Mapping of the inducible IκB phosphorylation sites that signal its ubiquitination and degradation. Mol Cell Biol 1996;16:1295-304.
12. Chen Z, Hagler J, Palombella VJ, et al. Signal-induced site-specific phosphorylation targets IκB-α to the ubiquitin-proteasome pathway. Genes Dev 1995;99:1586-97.
13. Sha WC, Liou HC, Tuomanen EI, et al. Targeted disurption of the p50 subunit of NF-κB leads to multifocal defects in immune responses. Cell 1995;80:321-30.
14. Stacey MA, Sun G, Vassalli G, et al. The allergen Der p1 induces NF-κB activation through interference with IκB alpha function in asthmatic bronchial epithelial cells. Biochem Biophys Res Commun 1997,236:522-6.
15. Zhu Z, Tang W, Ray A, et al. Rhinovirus stimulation of interleukin-6 in vivo and in vitro: evidence for nuclear factor κB-dependent transcriptional activation. J Clin Invest 1996,97:421-30.
16. Baeuerle PA, Baichwal VR. NF-κB as a frequent target for immunosuppressive and anti-inflammatory molecules. Adv Immunol 1997;65:111-38.
17. Blackwell TS, Christman JW. The role of nuclear factor-κB in cytokine gene regulation. Am J Respir Cell Mol Biol 1997; 17:3-9.
18. Toledano MB , Leonard WJ. Modulation of transcription factor NF-κB binding activity by oxidation-reduction in vitro. Proc Natl Acad Sci 1991;88:4328-32.
19. Schulze-Osthoff K, Los M, Baeuerle PA. Redox signalling by transcription factors NF-κB and AP-I in lymphocytes. Biochem Pharmacol 1995;50:735-41.
20. Richter, C, Cogvadze V, Laffranchi R, et al. Oxidants in mitochondria: from physiology to diseases. Biochim Biophys Acta 1995;127:67-74.
21. Shang F, Gong X, Taylor A. Activity of ubiquitin-dependent pathway in response to oxidative stress. Ubiquitin-activating enzyme is transiently up-regulated. J Biol Chem 1997;272:23086-93.
22. Shea LM, Beehler C, Schwartz M, et al. Hyperoxia activates NF-κB and increases TNF-α and IFN-γ gene expression mouse pulmonary lymphocytes. J Immunol 1996;157: 3902-8.
23. Haddad E-B, Salmon M, Koto H, et al. Ozone induction of cytokine-induced neutrophil chemoattractant (CINC) and nuclear factor-κB in rat lung: inhibition by corticosteroids. FEBS Lett 1996;379:265-8.
24. Schmidt KN, Amstad P, Cerutti P, et al. The roles of hydrogen peroxide and superoxide as messengers in the activation of transfactor factor NF-κB. Chem Biol 1995;2: 13-22.
25. Bowie, Moynagh PN, O'Neill LAJ. Lipid peroxidation is involved in the activation of NF-κB by tumor necrosis factor but not interleukin-1 in the human endothelial cell line ECV304. J Biol Chem 1997,272:25941-50.
26. Ginn-Pease ME, Whisler RL. Optimal NF-κB mediated transcriptional responses in Jurkat T cells exposed to oxidative stress are dependent on intracellular glutathione and costimulatory signals. Biochem Biophys Res Commun 1996;226:695-702.
27. Whiteside ST, Epinat JC, Rice NR, et al. I Kappa B epsilon, a novel member of the IκB family, controls RelA and cRel NF-κB activity. EMBO J 1997;16:1413-26.
28. Arenzana-Seisdedos F, Thompson J, Rodriguez MS, et al. Inducible nuclear expression of newly synthesised IκB-α negatively regulates DNA-binding and transcriptional activities of NF-κB. Mol Cell Biol 1995;15:2689-96.
29. Klement JF, Rice NR, Car BD, et al. Iκ-B-α deficiency results in a sustained NF-κB response and severe widespread dermatitis in mice. Mol Cell Biol 1996;16:2341-9.
30. Baeuerle PA, Baltimore D. NF-κB: ten years after. Cell 1996;87:13-20.
31. Scheinman RI, Cogswell PC, Lofquist AK, et al. Role of transcriptional activation of IκB-α in mediation of immunosuppression by glucocorticoids. Science 1995;270:283-6.
32. Kazmi, SM, Plante RK, Visconti V, et al. Suppression of NF-κB activation and NF-κB-dependent gene expression by tepoxalin, a dual inhibitor of cyclooxygenase and 5-lipoxygenase. J Cell Biochem 1995;57:299-310.
33. Wang, P, Wu P, Siegel MI, et al. Interleukin-10 inhibits NF-KB activation in human monocytes. J Biol Chem 1995; 270:95558-63.
34. Pahl HL, Krauss B, Schulze-Osthoff K, et al. The immunosuppressive fungal metabolite gliotoxin specically inhibits transcription factor NF-κB. J Exp Med 1996;183:1829-40.
35. Schenk H, Klein M, Erdbrugger W, et al. Distinct effects of thioredoxin and antioxidants on the activation of transcription factors NF-κB and AP-1. Proc Natl Acad Sci 1994;91: 1672-6.
36. Jun DY, Chae HZ, Rhee SG, et al. Regulatory role for a novel human thioredoxin peroxidase in NF-κB activation. J Biol Chem 1997;272:30952-61.
37. Malinin NL, Boldin MP, Kovalenko AV, et al. MAP3K-related kinase involved in NF-κB induction by TNF, CD95 and IL-1, Nature 1997;385:540-3.
38. Regnier CH, Song HY, Gao X, et al. Identification and characterisation of an IκB kinase. Cell 1997;90:373-83.
39. DiDonato JA, Hayakawa M, Rothward DM, et al. A cytokine-responsive IκB kinase that activates the transcription factor NF-κB. Nature 1997;388:548-54.
40. Woronicz JD, Gao X, Cao Z, et al. IκB kinase-β: NF-κB activation and complex formation with IκB kinase-α and NIK. Science 1997,278:866-9.
41. Zandi E, Rothward DM, Delhase M, et al. The IκB kinase complex (IKK) contains two kinase subunits, IKK-α and IKK-β, necessary for IκB phosphorylation and NF-κB activation. Cell 1997;91:243-52.
42. Beg AA, Finco TS, Nantermet PV, et al. TNF-α and IL-1 lead to phosphorylation and loss of IκB-α: a mechansim for NF-κB activation. Mol Cell Biol 1993;13:3301-10.
43. Lee FS, Hagler J, Chen ZJ, et al. Activation of the IκB-α kinase complex by MEKK1, a kinase of the JNK pathway. Cell 1997;88:213-22.
44. Thompson JE, Phillips RJ, Erdjument-Bromage H, et al. IκB-β regulates the persistent response in a biphasic activation of NF-κB. Cell 1995;80:573-82.
45. Philips RJ, Ghosh S. Regulation of IκB-β in WEHI 231 mature B cells. Mol Cell Biol 1997;17:4390-6.
46. Packman LC, Kubota K, Parker J, et al. Casein kinase II phosphorylates Ser468 in the PEST domain of the Drosophila IκB homologue cactus. FEBS Lett 1997;400:45-50.
47. Chesire JL, Baldwin AS Jr. Synergistic activation of NF-κB by tumour necrosis factor-alpha and gamma intereron via enhanced IκB-α degradation and de novo IκB-β degradation. Mol Cell Biol 1997;17:6746-54.
48. Xie QW, Kashiwabara Y, Nathan C. Role of transcription factor NF-κB/Rel in induction of nitric oxide synthase. J Biol Chem 1994;269:4705-8.
49. Ward PA. Role of complement, chemokines and regulatory cytokines in acute lung injury. Ann NY Acad Sci 1996;796: 104-12.
50. Albelda SM, Smith CW, Ward PA. Adhesion molecules and inflammatory injury. FASEB J 1994;8:504-12.
51. MacNee W, Rahman I. Oxidants antioxidants in idiopathic pulmonary fibrosis. Thorax 1995;50 (Suppl 1):S53-8.
52. Droge W, Schulze-Osthoff K, Mihm S, et al. Functions of glutathione and glutathione disulfide in immunology and immunopathology. FASEB J 1994;8:1131-8.
53. Chen CC, Manning AM. Transcriptional regulation of endothelial cell adhesion molecules: a dominant role for NF-κB. Agents Actions 1995;47 (Suppl):135-41.
54. Blackwell TS, Blackwell TR, Holden EP, et al. In vivo antioxidant treatment suppresses nuclear factor-κB activation and neutrophilic lung inflammation. J Immunol 1996;157: 1630-7.
55. Koong AC, Chen EY, Giaccia AJ. Hypoxia causes the activation of nuclear factor κB through the phosphorylation of IκB-α on tyrosine residues. Cancer Res 1994;54:1425-35.
56. Zund G, Uezono S, Stahl GL, et al. Hypoxia enhances induction of endothelial ICAM-1: role for metabolic acidosis and proteasomes. Am J Physiol 1997;273:C1571-80.
57. Gess B, Shricker K, Pfeifer M, et al. Acute hypoxia upregulates NOS gene expression in rats. Am J Physiol 1997;273: R905-10.
58. Metinko AP, Kunkel SL, Standiford TJ, et al. Anoxiahyperoxia induces monocyte-derived interleukin-8. J Clin Invest 1992;90:791-8.
59. Hsu H, Ziong J, Goeddel DV. The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation. Cell 1995;81:495-504.
60. Beg AA, Baltimore D. An essential role for NF-κB in preventing TNF-α induced cell death. Science 1996;274: 782-4.
61. Cai Z, Korner M, Tarantino N, et al. IκB-α overexpression in human breast carcinoma MCF7 cells inhibits nuclear factor-κB activation but not TNF-α induced apoptosis. J Biol Chem 1997;272:96-101.
62. Jany B, Betz R, Shreck R. Activation of the transcription factor NF-κB in human tracheobronchial epithelial cells by inflammatory stimuli. Eur Respir J 1995;8:387-91.
63. McDonald PP, Bald A, Cassatella MA. Activation of the NF-κB pathway by inflammatory stimuli in human neutrophils. Blood 1997;89:3421-33.
64. Barnes PJ, Adcock IM. NF-κB: a pivotal role in asthma and a new target for therapy. Trends Pharmacol Sci 1997;18:46-50.
65. Schwartz MD, Moore EE, Moore FA, et al. Nuclear factor-κB is activated in alveolar macrophages from patients with acute respiratory distress syndrome. Crit Care Med 1996;24:1285-92.
66. Shenkar R, Abraham E. Hemorrhage induces rapid in vivo activation of CREB and NF-κB in murine intraparenchymal lung mononuclear cells. Am J Respir Cell Mol Biol 1997;16:145-52.
67. Moine P, Shenkar R, Kaneko D, et al. Systemic blood loss affects NF-κB regulatory mechanisms in the lungs. Am J Physiol 1997;273:L185-92.
68. Tulzo YL, Shenkar R, Kaneko D, et al. Hemorrhage increases cytokine expression in lung monuclear cells in mice: involvement of catecholamines in NF-κB regulation and cytokine expression. J Clin Invest 1997;99:1516-24.
69. Ng KW, Ridgway P, Cohen DR, et al. The binding of a fos/ jun heterodimer can completely disrupt the structure of a nucleosome. EMBO J 1997;16:2072-85.
70. Karin M, Liu Z, Zandi E. AP-1 function and regulation. Curr Opin Cell Biol 1997;9:24-46.
71. 2-terminal kinases. J Biol Chem 1996;271:15703-7.
72. Moriguchi T, Toyoshima F, Masuyama N, et al. A novel SAPK/JNK kinase, MKK7, stimulated by TNF-α and cellular stresses. EMBO J 1997;16:7045-53.
73. Goldstone SD, Fragonas JC, Jeitner TM, et al. Transcription factors as targets for oxidative signalling during lymphocyte activation. Biochem Biophys Acta 1995;1263:114-22.
74. Wilhelm D, Bender K, Knebel A, et al. The level of intracellular glutathione is a key regulator for the induction of stress-activated signal transduction pathways including Jun N-terminal protein kinases and p38 kinase by alkylating agents. Mol Cell Biol 1997;17:4792-800.
75. Rahman I, Smith CAD, Lawson MF, et al. Induction of γ-glutamylcysteine synthetase by cigarette smoke is associated with AP-1 in human alveolar epithelial cells. FEBS Lett 1996;396:21-5.
76. Mio T, Romberger DJ, Thompson AB, et al. Cigarette smoke induces interleukin-8 release from human bronchial epithelial cells. Am J Respir Crit Care Med 1997;155:1770-6.
77. Choi HS, Moore DD. Induction of c-fos and c-jun gene expression by phenolic antioxidants. Mol Endocrinol 1993; 7:1596-606.
78. Beyaert R, Cuenda A, Vanden Berghe W, et al. The p38/RK mitogen-activated protein kinase pathway regulates interleukin-6 synthesis response to tumour necrosis factor. EMBO J 1996;15:1914-23.
79. Xie W, Herschman HR. v-src induces prostaglandin synthase 2 gene expression by activation of the c-Jun N-terminal kinase and the c-Jun transcription factor. J Biol Chem 1995;270:27622-8.
80. Levan TD, Bloom JW, Adams DG, et al. Platelet-activating factor induction of activator protein-1 signalling in bronchial epithelial cells. Mol Pharmacol 1998;53:135-40.
81. Wodrich W, Volm M. Overexpression of oncoproteins in non-small cell lung carcinomas of smokers. Carcinogenesis 1993;14:1121-4.
82. Haase M, Koslowski R, Lengnick A, et al. Cellular distribution of c-Jun and c-Fos in rat lung before and after bleomycin induced injury. Virchows Arch 1997;431:441-8.
83. Demoly P, Chanez P, Pujol JL, et al. Fos immunoreactivity assessment on human normal and pathological bronchial biopsies. Respir Med 1995;89:329-35.
84. Isshiki H, Akira S, Tanabe O, et al. Constitutive and IL-1 inducible factors interact with the IL-1 responsive element in the IL-6 gene. Mol Cell Biol 1990;10:2757-64.
85. Matsusaka T, Fujiwawa K, Nishio Y, et al. Transcription factors NF-IL6 and NF-κB synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8. Proc Natl Acad Sci 1993;90:10193-7.
86. Jamaluddin M, Garofalo R, Ogra PL, et al. Inducible translational regulation of the NF-IL6 transcription factor by respiratory syncytial virus infection in pulmonary epithelial cells. J Virol 1996;70:1554-63.
87. Spergel JM, Hsu W, Akira S, et al. NF-IL6, a member of the C/EBP family, regulates E1A-responsive promoters in the absence of E1A. J Virol 1992;66:1021-30.
88. Keicho N, Elliott WM, Hogg JC, et al. Adenovirus E1A gene dysregulates ICAM-1 expression in transformed pulmonary epithelial cells. Am J Respir Cell Mol Biol 1997;16:23-30.
89. Simeonova PP, Toriumi W, Kommineni C, et al. Molecular regulation of IL-6 activation by asbestos in lung epithelial cells: role of reactive oxygen species. J Immunol 1997;159: 3921-8.
90. 2+ response amplitude and duration. Nature 1997;386:855-8.
91. Zhang DH, Cohn L, Ray P, et al. Transcription factor GATA-3 is differentially expression in murine Th1 and Th2 cells and controls Th2-specific expression of the interkukin-5 gene. J Biol Chem 1997;272:21597-603.
92. Wofe SA, Zou P, Dotsch V, et al. Unusual Rel-like architecture in the DNA-binding domain of the transcription factor NFATc. Nature 1997;385:172-6.
93. Mattila PS, Ullman KS, Fiering S, et al. The action of cyclosporin A and FK506 suggest a novel step in the activation of T lymphocytes. EMBO J 1990;9:4425-33.
94. Paliogianni F, Raptis A, Ahuja SS, et al. Negative transcriptional regulation of human interleukin 2 (IL-2) gene by glucocorticoids through interference with nuclear transcription factors AP-1 and NF-AT. J Clin Invest 1993;91: 1481-9.
95. Stein B, Baldwin AS Jr, Ballard DW, et al. Cross-coupling of the NF-κB p65 and Fos/Jun transcription factors produces potentiated biological function. EMBO J 1993;12:3879-91.
96. Sica A, Dorman L, Viggiano V, et al. Intereraction of NF-kappaB and NFAT with the interferon-gamma promoter. J Biol Chem 1997;272:30412-20.
97. Newberry EP, Willis D, Latifi T, et al. Fibroblast growth factor receptor signaling activates the human interstitial collagenase promoter via the bipartite Ets-AP1 element. Mol Endocrinol 1997;11:1129-44.
98. Gupta S, Campbell D, Derijard B, et al. Transcription factor ATF2 regulation by the JNK signal transduction pathway. Science 1995;267:389-93.
99. Okamoto S, Mukaida N, Yasumoto K, et al. The interleukin-8 AP-1 and κB-like sites are genetic end targets of FK506-sensitive pathway accompanied by calcium mobilisation. J Biol Chem 1994;269:8582-9.
100. Read MA, Whitley MZ, Gupta S, et al. Tumor necrosis factor alpha-induced E-selectin expression is activated by the nuclear factor-kappa B and c-Jun N-terminal kinase/ p38 mitogen-activated protein kinase pathways. J Biol Chem 1997;272:2753-61.
101. Bennett BL, Cruz R, Lacson RG, et al. Interleukin-4 suppression of tumor necrosis factor alpha, stimulated E-selectin gene transcription is mediated by STAT6 antagonism of NF-kappa B. J Biol Chem 1997;272:10212-9.
102. Barnes PJ, Adcock I. Anti-inflammatory actions of steroids: molecular mechanisms. Trends Pharmacol Sci 1993;14:436-41.
103. John M, Au BT, Jose PJ, et al. Expression and release of interleukin-8 by human airway smooth muscle cells: inhibition by Th-2 cytokines and corticosteroids. Am J Respir Cell Mol Biol 1998;18:84-90.
104. Brostjan C, Anrather J, Csizmadia V, et al. Glucocorticoids inhibit E-selectin expression by targeting NF-κB and not ATF/c-Jun. J Immunol 1997;158:3836-44.
105. Yang-Yen HGF, Chambard JC, Sun YL, et al. Transcriptional interference between c-Jun and the glucocorticoid receptor: mutual inhibition of DNA binding due to direct protein-protein interaction. Cell 1990;62:1205-15.
106. Saag PT, Caldenhove E, Stolpe A. Molecular mechanisms of steroid action: a novel type of cross-talk between glucocorticoids and NF-κB transcription factors. Eur Respir J 1996;9:146-53s.
107. Adcock IM, Brown CR, Barnes PJ. Tumour necrosis factor-α causes retention of activated glucocorticoid receptor within the cytoplasm of A549 cells. Biochem Biophys Res Commun 1996;225:545-50.
108. Meagher LC, Cousin JM, Seckl J, et al. Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic and eosinophilic granulocytes. J Immunol 1996;156:4422-8.
109. Ura K, Kurumizaka H, Dimitrov S, et al. Histone acetylation: influence on transcription, nucleosome mobility and positioning, and linker histone-dependent transcriptional repression. EMBO J 1997;16:2096-107.
110. Spencer TE, Jenster G, Burcin MM, et al. Steroid receptor coactivator-1 is a histone acetyltransferase. Nature 1997; 389:194-8.
111. Yang XJ, Ogryzko VV, Nishikawa J, et al. A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A. Nature 1996;382:319-24.
112. Ogryzko VV, Schiltz RL, Russanova V, et al. The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 1996;87:953-9.
113. Mizzen CA, Yang XJ, Kokubo T, et al. The TAFII250 subunit of TFIID has histone acetyltransferase activity. Cell 1996;87:1261-70.
114. Kamei Y, Xu L, Heinzel T, et al. A CBP integrator complex mediates transcriptional activator and AP-1 inhibition by nuclear receptors. Cell 1996;85:1-12.
115. Jenster G, Spencer TE, Burcin MM, et al. Steroid receptor induction of gene transcription: a two-step model. Proc Natl Acad Sci 1997;94:7879-84.
116. Adcock IM, Lane SJ, Brown CR, et al. Abnormal glucocorticoid receptor-actvator protein 1 interaction in steroid-resistant asthma. J Exp Med 1995;182:1951-8.
117. Verma IM, Stevenson J. IκB kinase: beginning, not the end. Proc Natl Acad Sci 1997;94:11758-60.
118. Sen CK, Packer L. Antioxidant and redox regulation of gene transcription. FASEB J 1996;10:709-20.
119. Beg AA, Sha WC, Bronson RT, et al. Embroynic lethality and liver degeneration in mice lacking the Re1 A component of NF-κB. Nature 1995;376:167-70.